Stenzl Arnulf, Armstrong Andrew J, Sboner Andrea, Ghith Jenny, Serfass Lucile, Bland Christopher S, Schijvenaars Bob J A, Sternberg Cora N
Department of Urology, University Hospital Tübingen, Tübingen, Germany.
Department of Medicine, Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University, Durham, NC, USA.
Eur Urol Focus. 2024 Dec;10(6):1011-1018. doi: 10.1016/j.euf.2024.05.022. Epub 2024 Jun 13.
Defining optimal therapeutic sequencing strategies in prostate cancer (PC) is challenging and may be assisted by artificial intelligence (AI)-based tools for an analysis of the medical literature.
To demonstrate that INSIDE PC can help clinicians query the literature on therapeutic sequencing in PC and to develop previously unestablished practices for evaluating the outputs of AI-based support platforms.
DESIGN, SETTING, AND PARTICIPANTS: INSIDE PC was developed by customizing PubMed Bidirectional Encoder Representations from Transformers. Publications were ranked and aggregated for relevance using data visualization and analytics. Publications returned by INSIDE PC and PubMed were given normalized discounted cumulative gain (nDCG) scores by PC experts reflecting ranking and relevance.
INSIDE PC for AI-based semantic literature analysis.
INSIDE PC was evaluated for relevance and accuracy for three test questions on the efficacy of therapeutic sequencing of systemic therapies in PC.
In this initial evaluation, INSIDE PC outperformed PubMed for question 1 (novel hormonal therapy [NHT] followed by NHT) for the top five, ten, and 20 publications (nDCG score, +43, +33, and +30 percentage points [pps], respectively). For question 2 (NHT followed by poly [adenosine diphosphate ribose] polymerase inhibitors [PARPi]), INSIDE PC and PubMed performed similarly. For question 3 (NHT or PARPi followed by Lu-prostate-specific membrane antigen-617), INSIDE PC outperformed PubMed for the top five, ten, and 20 publications (+16, +4, and +5 pps, respectively).
We applied INSIDE PC to develop standards for evaluating the performance of AI-based tools for literature extraction. INSIDE PC performed competitively with PubMed and can assist clinicians with therapeutic sequencing in PC.
The medical literature is often very difficult for doctors and patients to search. In this report, we describe INSIDE PC-an artificial intelligence (AI) system created to help search articles published in medical journals and determine the best order of treatments for advanced prostate cancer in a much better time frame. We found that INSIDE PC works as well as another search tool, PubMed, a widely used resource for searching and retrieving articles published in medical journals. Our work with INSIDE PC shows new ways in which AI can be used to search published articles in medical journals and how these systems might be evaluated to support shared decision-making.
确定前列腺癌(PC)的最佳治疗顺序策略具有挑战性,基于人工智能(AI)的医学文献分析工具可能会有所帮助。
证明INSIDE PC可以帮助临床医生查询PC治疗顺序的文献,并制定以前未确立的评估基于AI的支持平台输出的方法。
设计、设置和参与者:INSIDE PC是通过定制来自变换器的PubMed双向编码器表示而开发的。使用数据可视化和分析对出版物进行排名和汇总以确定相关性。PC专家为INSIDE PC和PubMed返回的出版物给出反映排名和相关性的归一化折损累积增益(nDCG)分数。
用于基于AI的语义文献分析的INSIDE PC。
针对PC中全身治疗的治疗顺序疗效的三个测试问题,评估INSIDE PC的相关性和准确性。
在本次初步评估中,对于问题1(新型激素疗法[NHT]后接NHT),在前五、十和二十篇出版物中,INSIDE PC的表现优于PubMed(nDCG分数分别高43、33和30个百分点[pps])。对于问题2(NHT后接聚[腺苷二磷酸核糖]聚合酶抑制剂[PARPi]),INSIDE PC和PubMed表现相似。对于问题3(NHT或PARPi后接镥-前列腺特异性膜抗原-617),在前五、十和二十篇出版物中,INSIDE PC的表现优于PubMed(分别高16、4和5 pps)。
我们应用INSIDE PC制定了评估基于AI的文献提取工具性能的标准。INSIDE PC与PubMed相比具有竞争力,可协助临床医生进行PC的治疗排序。
医学文献对于医生和患者来说通常很难搜索。在本报告中,我们描述了INSIDE PC——一个人工智能(AI)系统,旨在帮助搜索医学期刊上发表的文章,并在更短的时间内确定晚期前列腺癌的最佳治疗顺序。我们发现INSIDE PC的效果与另一个搜索工具PubMed一样好,PubMed是一个广泛用于搜索和检索医学期刊上发表文章的资源。我们对INSIDE PC的研究展示了AI可用于搜索医学期刊上发表文章的新方法,以及如何评估这些系统以支持共同决策。